000 01883 a2200541 4500
005 20250515140750.0
264 0 _c20090729
008 200907s 0 0 eng d
022 _a1432-5233
024 7 _a10.1007/s00592-008-0064-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaczy, Boglárka
245 0 0 _aEffects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus.
_h[electronic resource]
260 _bActa diabetologica
_cJun 2009
300 _a105-11 p.
_bdigital
500 _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlbuminuria
_xphysiopathology
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAutonomic Nervous System
_xdrug effects
650 0 4 _aBlood Pressure
650 0 4 _aBody Mass Index
650 0 4 _aCreatinine
_xblood
650 0 4 _aDiabetes Mellitus, Type 2
_xcomplications
650 0 4 _aDiabetic Neuropathies
_xdrug therapy
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGlomerular Filtration Rate
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPentosan Sulfuric Polyester
_xtherapeutic use
650 0 4 _aPentoxifylline
_xtherapeutic use
650 0 4 _aPlacebos
650 0 4 _aSensory Thresholds
650 0 4 _aVasodilator Agents
_xtherapeutic use
650 0 4 _aVibration
700 1 _aCseh, Judit
700 1 _aMohás, Márton
700 1 _aMarkó, Lajos
700 1 _aTamaskó, Mónika
700 1 _aKoszegi, Tamás
700 1 _aMolnár, Gergo A
700 1 _aWagner, Zoltán
700 1 _aWagner, László
700 1 _aWittmann, István
773 0 _tActa diabetologica
_gvol. 46
_gno. 2
_gp. 105-11
856 4 0 _uhttps://doi.org/10.1007/s00592-008-0064-5
_zAvailable from publisher's website
999 _c18304994
_d18304994